Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm
Clinical trial NCT05027997 · COMPLETED
Trial details
- NCT number
- NCT05027997
- Sponsor
- Addex Pharma S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-06
- Primary completion
- 2022-10-27
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.